AVITHRAPID
@avithrapid.bsky.social
The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
November 12, 2025 at 8:35 AM
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
Small molecules are a flexible and scalable tool for new and resistant viruses.
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
November 4, 2025 at 12:11 PM
Small molecules are a flexible and scalable tool for new and resistant viruses.
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
October 23, 2025 at 2:24 PM
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
Today is Global Handwashing Day.
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
October 15, 2025 at 12:18 PM
Today is Global Handwashing Day.
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
October 9, 2025 at 7:02 AM
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
September 23, 2025 at 3:29 PM
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
September 18, 2025 at 7:38 AM
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
August 27, 2025 at 4:39 PM
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
August 19, 2025 at 3:32 PM
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
August 13, 2025 at 11:43 AM
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
Who’s behind AVITHRAPID?
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
August 5, 2025 at 12:39 PM
Who’s behind AVITHRAPID?
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
From hepatitis C to tomorrow’s viruses: AVITHRAPID builds on proven science to prepare for future outbreaks.
#WorldHepatitisDay #ScienceFeed
#WorldHepatitisDay #ScienceFeed
July 28, 2025 at 10:31 AM
From hepatitis C to tomorrow’s viruses: AVITHRAPID builds on proven science to prepare for future outbreaks.
#WorldHepatitisDay #ScienceFeed
#WorldHepatitisDay #ScienceFeed
AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics.
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.
#AVITHRAPID #ScienceFeed #PandemicResponse
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.
#AVITHRAPID #ScienceFeed #PandemicResponse
July 25, 2025 at 5:04 PM
AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics.
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.
#AVITHRAPID #ScienceFeed #PandemicResponse
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.
#AVITHRAPID #ScienceFeed #PandemicResponse
What’s next for AVITHRAPID?
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.
#AVITHRAPID #PandemicPreparedness #OneHealth
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.
#AVITHRAPID #PandemicPreparedness #OneHealth
July 18, 2025 at 6:58 PM
What’s next for AVITHRAPID?
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.
#AVITHRAPID #PandemicPreparedness #OneHealth
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.
#AVITHRAPID #PandemicPreparedness #OneHealth
🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
July 10, 2025 at 6:13 AM
🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
Neglected tropical diseases (NTDs) affect over 1.5 billion people worldwide, yet treatment options remain limited. Broad-spectrum antivirals offer a promising solution. Let’s push for innovation and progress. Stay informed on the latest updates—subscribe to our newsletter at www.avithrapid.eu
June 12, 2025 at 6:30 AM
Neglected tropical diseases (NTDs) affect over 1.5 billion people worldwide, yet treatment options remain limited. Broad-spectrum antivirals offer a promising solution. Let’s push for innovation and progress. Stay informed on the latest updates—subscribe to our newsletter at www.avithrapid.eu
Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation
June 11, 2025 at 6:30 AM
Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation
Market gaps in broad-spectrum #antivirals are clear: limited #discovery platforms, resistance concerns, clinical trial barriers, and access issues. It’s time to bridge these gaps and innovate to protect global health. Subscribe to our newsletter: www.avithrapid.eu
June 10, 2025 at 6:30 AM
Market gaps in broad-spectrum #antivirals are clear: limited #discovery platforms, resistance concerns, clinical trial barriers, and access issues. It’s time to bridge these gaps and innovate to protect global health. Subscribe to our newsletter: www.avithrapid.eu
The world isn’t short on brilliant science.
It’s short on collaboration, clarity, and courage.
In the face of the next crisis, how we organize knowledge may matter more than how we generate it.
We can’t afford siloed thinking anymore.
#AVITHRAPID
It’s short on collaboration, clarity, and courage.
In the face of the next crisis, how we organize knowledge may matter more than how we generate it.
We can’t afford siloed thinking anymore.
#AVITHRAPID
June 5, 2025 at 6:14 AM
The world isn’t short on brilliant science.
It’s short on collaboration, clarity, and courage.
In the face of the next crisis, how we organize knowledge may matter more than how we generate it.
We can’t afford siloed thinking anymore.
#AVITHRAPID
It’s short on collaboration, clarity, and courage.
In the face of the next crisis, how we organize knowledge may matter more than how we generate it.
We can’t afford siloed thinking anymore.
#AVITHRAPID
Meet Paulo da Silva, R&D Specialist at @IT4Innovations 🇨🇿 & key partner in #AVITHRAPID. With HPC expertise, Paulo drives the in-silico engines accelerating antiviral discovery. 🧬💻
🎥 Watch the video & see how supercomputing helps fight pandemics!
#DrugDiscovery #HPC #PandemicPreparedness
🎥 Watch the video & see how supercomputing helps fight pandemics!
#DrugDiscovery #HPC #PandemicPreparedness
June 4, 2025 at 6:31 AM
Meet Paulo da Silva, R&D Specialist at @IT4Innovations 🇨🇿 & key partner in #AVITHRAPID. With HPC expertise, Paulo drives the in-silico engines accelerating antiviral discovery. 🧬💻
🎥 Watch the video & see how supercomputing helps fight pandemics!
#DrugDiscovery #HPC #PandemicPreparedness
🎥 Watch the video & see how supercomputing helps fight pandemics!
#DrugDiscovery #HPC #PandemicPreparedness
AVITHRAPID was showcased at #AREVIR2025 in Cologne!
Francesca Incardona presented our mission to a hybrid audience of 120+ experts in infectious diseases, virology & AI.
Thanks to the organizers for the spotlight!
🌐 www.avithrapid.eu
#HorizonEU #OneHealth
Francesca Incardona presented our mission to a hybrid audience of 120+ experts in infectious diseases, virology & AI.
Thanks to the organizers for the spotlight!
🌐 www.avithrapid.eu
#HorizonEU #OneHealth
May 12, 2025 at 7:41 AM
AVITHRAPID was showcased at #AREVIR2025 in Cologne!
Francesca Incardona presented our mission to a hybrid audience of 120+ experts in infectious diseases, virology & AI.
Thanks to the organizers for the spotlight!
🌐 www.avithrapid.eu
#HorizonEU #OneHealth
Francesca Incardona presented our mission to a hybrid audience of 120+ experts in infectious diseases, virology & AI.
Thanks to the organizers for the spotlight!
🌐 www.avithrapid.eu
#HorizonEU #OneHealth
🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access
April 11, 2025 at 6:30 AM
🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access
🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
PLpro Inhibitors Poster – Presented by Antonietta Mollo
✔️ 7 validated molecular clusters
✔️ Hits in µM IC50 range
✔️ No toxicity, modest antiviral activity
✔️ X-ray co-crystallization & SAR studies ongoing
PLpro Inhibitors Poster – Presented by Antonietta Mollo
✔️ 7 validated molecular clusters
✔️ Hits in µM IC50 range
✔️ No toxicity, modest antiviral activity
✔️ X-ray co-crystallization & SAR studies ongoing
April 10, 2025 at 6:30 AM
🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
PLpro Inhibitors Poster – Presented by Antonietta Mollo
✔️ 7 validated molecular clusters
✔️ Hits in µM IC50 range
✔️ No toxicity, modest antiviral activity
✔️ X-ray co-crystallization & SAR studies ongoing
PLpro Inhibitors Poster – Presented by Antonietta Mollo
✔️ 7 validated molecular clusters
✔️ Hits in µM IC50 range
✔️ No toxicity, modest antiviral activity
✔️ X-ray co-crystallization & SAR studies ongoing
Meet the AVITHRAPID Consortium 🧪🔬
How are antiviral compounds screened and optimized? Francesca Esposito, Associate Professor at Università degli Studi di Cagliari, is developing biochemical assays to identify and refine antiviral inhibitors.
🎥 Watch the short video to learn more!
How are antiviral compounds screened and optimized? Francesca Esposito, Associate Professor at Università degli Studi di Cagliari, is developing biochemical assays to identify and refine antiviral inhibitors.
🎥 Watch the short video to learn more!
March 11, 2025 at 7:28 AM
Meet the AVITHRAPID Consortium 🧪🔬
How are antiviral compounds screened and optimized? Francesca Esposito, Associate Professor at Università degli Studi di Cagliari, is developing biochemical assays to identify and refine antiviral inhibitors.
🎥 Watch the short video to learn more!
How are antiviral compounds screened and optimized? Francesca Esposito, Associate Professor at Università degli Studi di Cagliari, is developing biochemical assays to identify and refine antiviral inhibitors.
🎥 Watch the short video to learn more!
📈 The Future of Antivirals is Here From AI-powered drug discovery to real-world clinical trials, we’re rewriting the rules of antiviral development. Don’t miss out! avithrapid.eu/newsle...
March 9, 2025 at 8:05 AM
📈 The Future of Antivirals is Here From AI-powered drug discovery to real-world clinical trials, we’re rewriting the rules of antiviral development. Don’t miss out! avithrapid.eu/newsle...